List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 242 studies with search of: "UCB" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Enrolling by invitation A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (ucb 34714)
2 Completed Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Sodium Oxybate (Xyrem)
3 Completed Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
Condition: Epilepsy, Partial
Intervention: Drug: Levetiracetam
4 Completed Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin
Conditions: Allergic Rhinitis;   Chronic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Placebo
5 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
6 Completed Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
Condition: Epilepsy, Partial
Intervention: Drug: Seletracetam (ucb 44212)
7 Completed Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy
Condition: Epilepsy
Intervention: Drug: LEVETIRACETAM (UCB)
8 Completed CUTE (Chronic Urticaria Treatment Evaluation)
Condition: Chronic Idiopathic Urticaria
Interventions: Drug: Levocetirizine;   Drug: Desloratadine
9 Completed Efficacy of re-Treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: Certolizumab pegol (cimzia®)
10 Completed A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy
Condition: Painful Diabetic Neuropathy
Intervention: Drug: SPM 929
11 Completed Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
Condition: Epilepsy
Intervention: Drug: Levetiracetam
12 Active, not recruiting To Determine Tolerability and Efficacy of Long-Term Oral Lacosamide in Patients With Partial Seizures
Condition: Partial Epilepsies
Intervention: Drug: lacosamide
13 Terminated Study of Epratuzumab in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: epratuzumab
14 Active, not recruiting Study to Assess the Safety of CDP870 for up to 84 Months Following Reintroduction of Treatment
Condition: Crohn's Disease
Intervention: Biological: CDP870
15 Completed Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine
Condition: Parkinson's Disease
Intervention: Drug: Rotigotine
16 Completed Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis
Condition: Rhinitis, Allergic, Seasonal
Intervention: Drug: levocetirizine dihydrochloride
17 Completed A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rotigotine
18 Active, not recruiting Extension Study to Evaluate Safety, Efficacy, and Corticosteroid Sparing Effect of Certolizumab in Patients With Crohn's Disease.
Condition: Crohn's Disease
Intervention: Biological: Certolizumab pegol
19 Completed Phase 3 Open-Label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
Condition: Idiopathic Restless Legs Syndrome
Intervention: Drug: Rotigotine
20 Completed Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months
Conditions: Allergic Rhinitis;   Chronic Urticaria
Interventions: Drug: Levocetirizine;   Other: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services